Whereas all medication offered to American shoppers face a rigorous approval course of, that is not the case in the case of dietary supplements. The Meals and Drug Administration (FDA) doesn’t approve dietary supplements, and whereas there are some limits to the claims that may be made by corporations on this house, there is a truthful quantity of latitude.
“The producer will need to have substantiation that the declare is truthful and never deceptive and should submit a notification with the textual content of the declare to FDA no later than 30 days after advertising and marketing the dietary complement with the declare. If a dietary complement label consists of such a declare, it should state in a ‘disclaimer’ that FDA has not evaluated the declare,” in accordance with the FDA web site.
Complement makers could make sure construction/operate claims with out FDA preapproval, so long as they’ve substantiation that the claims are truthful and never deceptive, and that they meet the company’s different necessities.
“The disclaimer should additionally state that the dietary complement product will not be supposed to ‘diagnose, deal with, treatment or stop any illness,’ as a result of solely a drug can legally make such a declare,” the federal company shared.
It is a authorized gray space that enables dietary supplements to promote that they can assist with health, hair development, sleep, and your capability to focus.
Synergy CHC Corp., the maker of Focus Issue, which is described on its Amazon gross sales web page as a “Mind Complement for Reminiscence, Focus and Focus,” has filed for Chapter 11 chapter.
Focus Issue has been a bestseller
Synergy makes some daring claims about what Focus Issue can do for shoppers.
Focus Issue Additional Power mind dietary supplements include a strong mixture of nutritional vitamins, minerals, and neuro-nutrients that not solely energy your mind however may also substitute your every day multivitamin,” it shared.
The corporate, on Amazon, additionally mentioned that the complement promotes focus and reminiscence.
“Like different elements of your physique, your mind wants correct diet to carry out its greatest. This superior formulation improves and enhances reminiscence, focus, and your capability to focus,” it added.
Synergy CHC backs that up with the next declare that does not immediately converse to efficacy.
“Focus Issue is the #1 Pharmacist Really helpful Model based mostly on the outcomes of the U.S. Pharmacy Occasions Survey of Pharmacists’ OTC Suggestions for ‘Reminiscence Help’ dietary complement, 2025-2026,” the corporate shared.
Synergy CHC Corp. develops and markets client well being and wellness merchandise, led by its flagship manufacturers Focus Issue and Flat Tummy.
“Focus Issue, a clinically studied mind well being complement and purposeful beverage line with a 25-year legacy, enjoys established distribution within the U.S., Canada, and Mexico by means of main retailers together with Walmart, Amazon, BJ’s, and Walgreens, amongst others. Flat Tummy enhances Synergy’s portfolio as a way of life model centered on girls’s wellness and weight administration,” the corporate shared in a press launch.
Focus Issue maker misplaced its Costco deal
Synergy CHC warned of potential vital monetary issues after it obtained discover from Costco that the warehouse membership could be dropping the corporate’s merchandise.
“On July 15, 2026, Costco Wholesale Company knowledgeable Synergy CHC Corp. that Costco will discontinue carrying the Firm’s Focus Issue merchandise. Costco has been a big buyer of the Firm for greater than 16 years,” it shared in an SEC submitting.
Extra Retail:
It is necessary to notice that Costco didn’t share a purpose for dropping Synergy CHC’s manufacturers.
“Costco accounted for roughly 58% of the Firm’s internet income throughout the fiscal 12 months ended December 31, 2025. The Firm expects Costco’s choice to have a fabric antagonistic impact on the Firm’s enterprise, outcomes of operations, liquidity, and monetary situation and is evaluating accessible financing and different strategic options,” the submitting continued.
Costco nonetheless sells dietary supplements and purposeful drinks
Costco continues to promote different complement manufacturers and not too long ago added Hiyo, a drink line that falls into the purposeful beverage house.
“Made with natural adaptogens, pure nootropics, and purposeful botanicals, every can provides what the model calls a ‘mood-enhancing, stress-relieving elevate,’ or ‘the float,’ in accordance with a press launch.
The U.S. Meals and Drug Administration regulates components and requires drink labels to be truthful, and the Federal Commerce Fee can step in if corporations make false claims.
“Useful beverage makers typically make much less particular claims, and the science behind them is typically inconclusive. SkinTe, a glowing tea, says it ‘helps pores and skin hydration and elasticity’ with 3,000 milligrams of collagen in a 12-ounce can. However final 12 months, Harvard Medical College researchers mentioned there’s not but stable proof that collagen drinks or dietary supplements improve pores and skin, hair, or nail development,” in accordance with The Chicago Solar-Occasions.
Useful drinks are a rising class.Shutterstock
Synergy CHC Chapter 11 chapter at a look
Synergy CHC Corp., the client healthcare firm, publicly traded as SNYR, filed Chapter 11 on Sept. 4, 2026, within the U.S. Chapter Court docket for the District of Columbia, case 26-00465.
Its petition identifies its DBAs as Synergy Strips Corp. and Focus Issue Diet Labs.
Headquarters: Sebago, Maine
Property: $1 million to $10 million
Liabilities: $10 million to $50 million
Collectors: 1-49
Companies/manufacturers listed on the petition: Synergy Strips Corp., Focus Issue, and Issue Diet Labs.
Synergy Reorg, LLC, which occurs to share the Synergy title, additionally filed for Chapter 11 chapter on Sept. 4. Regardless of the same title, the 2 instances don’t seem like related.
Associated: Barbecue chain closed extra eating places than it admitted
NASDAQ sends Synergy a warning
Synergy CHC Corp. obtained a discover from The Nasdaq Inventory Market on August 20 indicating that the corporate will not be in compliance with Nasdaq Itemizing Rule 5250(c)(1) because of the delayed submitting of its Quarterly Report on Type 10-Q for the quarter ended June 30, 2026 with the Securities and Change Fee (the “SEC”).
The Itemizing Rule requires corporations with securities listed on Nasdaq to well timed file all required periodic studies with the SEC.
That discover led to the agent of the corporate’s lender, ACP Company, LLC, sending CHC an Acceleration Discover.
“The Acceleration Discover states that, following the Occasions of Default beforehand disclosed by the corporate in its Present Report on Type 8-Ok filed on August 11, 2026, ACP, on the route of the required lenders, has exercised cures below the Credit score Settlement,” in accordance with an SEC submitting.
That discover signifies that CHC’s lenders will not prolong the corporate any extra credit score and wish to be repaid in full.
“The Acceleration Discover additional states that, as of August 21, 2026, roughly $18.9 million was instantly due and payable below the Credit score Settlement and associated mortgage paperwork, unique of further curiosity, charges, prices and bills that proceed to accrue,” the submitting continued.
CHC Synergy continues to function below its Chapter 11 chapter submitting. The corporate has not shared it plans going ahead.
ALSO READ: Costco silently kills member perk that saved prospects cash
This story was initially revealed by TheStreet on Sep 7, 2026, the place it first appeared within the Retail part. Add TheStreet as a Most well-liked Supply by clicking right here.
